Current insights into animal models of graves' disease and orbitopathy

Hormone and Metabolic Research

Volumn 45, Issue 8, 2013, Pages 549-555

  Wiesweg, B ^a   Johnson, K T M ^a   Eckstein, A K ^a   Berchner Pfannschmidt, U ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

autoimmunity; genetic immunization; mouse orbit; murine models; TSHR antibodies

Indexed keywords

THYROID HORMONE; THYROID STIMULATING IMMUNOGLOBULIN;

ADIPOGENESIS; ANIMAL MODEL; ENDOCRINE OPHTHALMOPATHY; GENETIC IMMUNIZATION; GRAVES DISEASE; HUMAN; MYOFIBROSIS; NONHUMAN; ORBIT; PRIORITY JOURNAL; REVIEW; THYROID FOLLICLE CELL; THYROID HORMONE RELEASE;

ANIMALS; DISEASE MODELS, ANIMAL; GRAVES DISEASE; HUMANS; MICE; ORBITAL DISEASES; RECEPTORS, THYROTROPIN;

ANIMALIA; MURINAE; MUS;

EID: 84880506579     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1343451     Document Type: Review

References (47)

1. Wiersinga W. M., Bartalena L. Epidemiology and prevention of Graves' ophthalmopathy. Thyroid: 2002; 12 855 860 (Pubitemid 35332989)
2. Zophel K., Roggenbuck D., von Landenberg P., Wunderlich G., Gruning T., Kotzerke J., Lackner K. J., Rees Smith B. TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays. Horm Metab Res: 2010; 42 65 69
3. Ludgate M., Crisp M., Lane C., Costagliola S., Vassart G., Weetman A., Daunerie C., Many M. C. The thyrotropin receptor in thyroid eye disease. Thyroid: 1998; 8 411 413 (Pubitemid 28252423)
4. Many M. C., Costagliola S., Detrait M., Denef F., Vassart G., Ludgate M. C. Development of an animal model of autoimmune thyroid eye disease. J Immunol: 1999; 162 4966 4974 (Pubitemid 29314904)
5. Johnson K. T., Wiesweg B., Schott M., Ehlers M., Müller M., Minich W. B., Nagayama Y., Gulbins E., Eckstein A. K., Berchner-Pfannschmidt U. Examination of Orbital Tissues in Murine Models of Graves' Disease reveals expression of UCP-1 and the TSHR in retrobulbar adipose tissues. Horm Metab Res: 2013; [Epub ahead of print]
6. Prabhakar B. S., Bahn R. S., Smith T. J. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev: 2003; 24 802 835 (Pubitemid 38067700)
7. Noh J. Y., Hamada N., Inoue Y., Abe Y., Ito K. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Thyroid: 2000; 10 809 813
8. Subekti I., Boedisantoso A., Moeloek N. D., Waspadji S., Mansyur M. Association of TSH receptor antibody, thyroid stimulating antibody, and thyroid blocking antibody with clinical activity score and degree of severity of graves ophthalmopathy. Acta Medica Indonesiana: 2012; 44 114 121
9. Eckstein A. K., Plicht M., Lax H., Neuhauser M., Mann K., Lederbogen S., Heckmann C., Esser J., Morgenthaler N. G. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab: 2006; 91 3464 3470 (Pubitemid 44402120)
10. Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu Exp Animals: 1980; 29 1 13 (Pubitemid 10185796)
11. Ludgate M., Baker G. Inducing Graves' ophthalmopathy. J Endocrinol Invest: 2004; 27 211 215 (Pubitemid 38607472)
12. Shimojo N., Kohno Y., Yamaguchi K., Kikuoka S., Hoshioka A., Niimi H., Hirai A., Tamura Y., Saito Y., Kohn L. D., Tahara K. Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci USA: 1996; 93 11074 11079 (Pubitemid 26333120)
13. Kaithamana S., Fan J., Osuga Y., Liang S. G., Prabhakar B. S. Induction of experimental autoimmune Graves' disease in BALB/c mice. J Immunol: 1999; 163 5157 5164 (Pubitemid 29501285)
14. Kita-Furuyama M., Nagayama Y., Pichurin P., McLachlan S. M., Rapoport B., Eguchi K. Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves' hyperthyroidism in BALB/c mice. Clin Exp Immunol: 2003; 131 234 240 (Pubitemid 36205133)
15. Nagayama Y., Kita-Furuyama M., Ando T., Nakao K., Mizuguchi H., Hayakawa T., Eguchi K., Niwa M. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor. J Immunol: 2002; 168 2789 2794 (Pubitemid 34211657)
16. Chen C. R., Pichurin P., Nagayama Y., Latrofa F., Rapoport B., McLachlan S. M. The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim. J Clin Invest: 2003; 111 1897 1904 (Pubitemid 38057734)
17. Smelser G. K. The histology of orbital and other fat tissue deposits in animals with experimentally produced exophthalmos. Am J Pathol: 1939; 15 341 352
18. Costagliola S., Alcalde L., Tonacchera M., Ruf J., Vassart G., Ludgate M. Induction of thyrotropin receptor (TSH-R) autoantibodies and thyroiditis in mice immunised with the recombinant TSH-R. Biochem Biophys Res Commun: 1994; 199 1027 1034
19. Patibandla S. A., Fan J. L., Prabhakar B. S., Seetharamaiah G. S. Comparison of immune responses to extracellular domains of mouse and human thyrotropin receptor. J Autoimmun: 1999; 13 205 213 (Pubitemid 29436135)
20. Bottazzo G. F., Pujol-Borrell R., Hanafusa T., Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet: 1983; 2 1115 1119
21. Ando T., Imaizumi M., Graves P., Unger P., Davies T. F. Induction of thyroid-stimulating hormone receptor autoimmunity in hamsters. Endocrinology: 2003; 144 671 680 (Pubitemid 36205241)
22. Pichurin P., Yan X. M., Farilla L., Guo J., Chazenbalk G. D., Rapoport B., McLachlan S. M. Naked TSH receptor DNA vaccination: A TH1 T cell response in which interferon-gamma production, rather than antibody, dominates the immune response in mice. Endocrinology: 2001; 142 3530 3536 (Pubitemid 32681761)
23. Rao P. V., Watson P. F., Weetman A. P., Carayanniotis G., Banga J. P. Contrasting activities of thyrotropin receptor antibodies in experimental models of Graves' disease induced by injection of transfected fibroblasts or deoxyribonucleic acid vaccination. Endocrinology: 2003; 144 260 266 (Pubitemid 36076115)
24. Land K. J., Moll J. S., Kaplan M. H., Seetharamaiah G. S. Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism. Endocrinology: 2004; 145 3724 3730 (Pubitemid 39037558)
25. McLachlan S. M., Nagayama Y., Rapoport B. Insight into Graves' hyperthyroidism from animal models. Endocr Rev: 2005; 26 800 832 (Pubitemid 41428539)
26. Mizutori Y., Saitoh O., Eguchi K., Nagayama Y. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice. J Autoimmun: 2006; 26 32 36 (Pubitemid 43138890)
27. Costagliola S., Rodien P., Many M. C., Ludgate M., Vassart G. Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. J Immunol: 1998; 160 1458 1465 (Pubitemid 28093448)
28. Baker G., Mazziotti G., von Ruhland C., Ludgate M. Reevaluating thyrotropin receptor-induced mouse models of Graves' disease and ophthalmopathy. Endocrinology: 2005; 146 835 844 (Pubitemid 40129841)
29. Yamada M., Li A. W., West K. A., Chang C. H., Wall J. R. Experimental model for ophthalmopathy in BALB/c and outbred (CD-1) mice genetically immunized with G2s and the thyrotropin receptor. Autoimmunity: 2002; 35 403 413 (Pubitemid 35252232)
30. Costagliola S., Many M. C., Denef J. F., Pohlenz J., Refetoff S., Vassart G. Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves disease. J Clin Invest: 2000; 105 803 811 (Pubitemid 30164119)
31. Ho S. C., Goh S. S., Kee I. H., Chow P. K., Yeo C. P., Khoo D. H. Effects of genetic immunization of Swiss outbred mice with human thyroid stimulating hormone receptor cDNA plasmids harboring gain-of-function mutations. J Mol Endocrinol: 2007; 38 277 288 (Pubitemid 46351609)
32. Chazenbalk G. D., Pichurin P., Chen C. R., Latrofa F., Johnstone A. P., McLachlan S. M., Rapoport B. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. J Clin Invest: 2002; 110 209 217 (Pubitemid 34787358)
33. Chen C. R., Pichurin P., Chazenbalk G. D., Aliesky H., Nagayama Y., McLachlan S. M., Rapoport B. Low-dose immunization with adenovirus expressing the thyroid-stimulating hormone receptor A-subunit deviates the antibody response toward that of autoantibodies in human Graves' disease. Endocrinology: 2004; 145 228 233 (Pubitemid 38094521)
34. Land K. J., Gudapati P., Kaplan M. H., Seetharamaiah G. S. Differential requirement of signal transducer and activator of transcription-4 (Stat4) and Stat6 in a thyrotropin receptor-289-adenovirus-induced model of Graves' hyperthyroidism. Endocrinology: 2006; 147 111 119 (Pubitemid 43004266)
35. Gilbert J. A., Kalled S. L., Moorhead J., Hess D. M., Rennert P., Li Z., Khan M. Z., Banga J. P. Treatment of autoimmune hyperthyroidism in a murine model of Graves' disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology. Endocrinology: 2006; 147 4561 4568 (Pubitemid 44402161)
36. Wu L., Xun L., Yang J., Xu L., Tian Z., Gao S., Zhang Y., Hou P., Shi B. Induction of murine neonatal tolerance against Graves' disease using recombinant adenovirus expressing the TSH receptor A-subunit. Endocrinology: 2011; 152 1165 1171
37. Ye F., Hou P., Wu X., Ma X., Gao L., Wu L., Xu L., Shi B. The significance of immune-related molecule expression profiles in an animal model of Graves' disease. Autoimmunity: 2012; 45 143 152
38. Saitoh O., Nagayama Y. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model. Endocrinology: 2006; 147 2417 2422
39. Jacobs B., Papewalis C., Ehlers M., Schott M. Endocrine organs under the control of the immune system: potential implications for cellular therapies. Horm Metab Res: 2010; 42 912 917
40. Zhao S. X., Tsui S., Cheung A., Douglas R. S., Smith T. J., Banga J. P. Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA. J Endocrinol: 2011; 210 369 377
41. Weightman D. R., Perros P., Sherif I. H., Kendall-Taylor P. Autoantibodies to IGF-1 binding sites in thyroid associated ophthalmopathy. Autoimmunity: 1993; 16 251 257 (Pubitemid 24111622)
42. Pritchard J., Han R., Horst N., Cruikshank W. W., Smith T. J. Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway. J Immunol: 2003; 170 6348 6354 (Pubitemid 36682621)
43. Smith T. J. The putative role of fibroblasts in the pathogenesis of Graves' disease: evidence for the involvement of the insulin-like growth factor-1 receptor in fibroblast activation. Autoimmunity: 2003; 36 409 415 (Pubitemid 37160530)
44. Endo T., Kobayashi T. Thyroid-stimulating hormone receptor in brown adipose tissue is involved in the regulation of thermogenesis. American journal of physiology Endocrinology and metabolism: 2008; 295 E514 E518
45. Zhang L., Baker G., Janus D., Paddon C. A., Fuhrer D., Ludgate M. Biological effects of thyrotropin receptor activation on human orbital preadipocytes. Invest Ophthalmol Vis Sci: 2006; 47 5197 5203 (Pubitemid 46723765)
46. Nakahara M., Johnson K., Eckstein A., Taguchi R., Yamada M., Abiru N., Nagayama Y. Adoptive transfer of antithyrotropin receptor (TSHR) autoimmunity from TSHR knockout mice to athymic nude mice. Endocrinology: 2012; 153 2034 2042
47. Nakahara M., Mitsutake N., Sakamoto H., Chen C. R., Rapoport B., McLachlan S. M., Nagayama Y. Enhanced response to mouse thyroid-stimulating hormone (TSH) receptor immunization in TSH receptor-knockout mice. Endocrinology: 2010; 151 4047 4054